A Case of Therapy-Related Acute Leukemia With Mixed Phenotype With BCR-ABL1 After Treatment of Diffuse Large B-Cell Lymphoma

Dahae YANG; Sung-Ran CHO; Seri JUNG; Woonhyoung LEE; Hyun-Yong HWANG; Ho-Seop LEE; Yang-Soo KIM; Jong-Rak CHOI; Mi-Hyang KIM.
Annals of Laboratory Medicine ; : 166-168, 2017.
Artículo en Inglés | WPRIM | ID: wpr-8643

Documentos relacionados

  1. A Case of Therapy-Related Acute Leukemia With Mixed Phenotype With BCR-ABL1 After Treatment of Diffuse Large B-Cell Lymphoma.
  2. Clinical and Molecular Characteristics of Patients with Mixed Phenotype Acute Leukemia.
  3. Protein Tyrosine Phosphatase Receptor Gamma as Potential Therapeutic Target for Chronic Myeloid Leukemia Patients.
  4. Asymmetric Hairpins DNA Encapsulated Silver Nanoclusters for In Situ Fluorescence Imaging of Fusion Gene Isoforms in Bone Marrow.
  5. Lineage-specific detection of residual disease predicts relapse in patients with chronic myeloid leukemia stopping therapy.
  6. Development and evaluation of a rapid one-step high sensitivity real-time quantitative PCR system for minor BCR-ABL (e1a2) test in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
  7. Variable characteristics overlooked in human K-562 leukemia cell lines with a common signature.
  8. IGJ and SPATS2L immunohistochemistry sensitively and specifically identify BCR::ABL1+ and BCR::ABL1-like B-acute lymphoblastic leukaemia.
  9. [The Evolution of the Treatment of Chronic Myelogenous Leukemia].
  10. 'Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting.